Literature DB >> 11137441

Role of the angiotensin receptor in the development of the mammalian kidney and urinary tract.

Y Miyazaki1, I Ichikawa.   

Abstract

Recent gene targeting and pharmacological studies have shown that the renin-angiotensin system is essential for the development of the mammalian kidney and urinary tract system. We have generated mutant mice carrying a targeted null mutation of the angiotensin type 1 receptor (AT1) or type 2 receptor (AT2) gene. Analyses of these two mutant mice revealed that both mutants have a distinct phenotype in the kidney and urinary tract system. Thus, some AT2 null mutants (Agtr2 -/Y) show anomalies that mimic human congenital anomalies of the kidney and urinary tract as a result of a defect in the in utero organogenesis of the excretory system, while AT1 null mutants (Agtr1 -/-) exhibit hydronephrosis due to a defective development of the urinary peristaltic machinery during the perinatal period. In this review, we discuss chronologically from embryos to adults how the angiotensin receptors regulate the morphogenesis of the excretory system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11137441     DOI: 10.1016/s1095-6433(00)00299-3

Source DB:  PubMed          Journal:  Comp Biochem Physiol A Mol Integr Physiol        ISSN: 1095-6433            Impact factor:   2.320


  2 in total

1.  Magnetic resonance imaging of urea transporter knockout mice shows renal pelvic abnormalities.

Authors:  Vinitha A Jacob; Calista M Harbaugh; John R Dietz; Robert A Fenton; Soo M Kim; Hayo Castrop; Jurgen Schnermann; Mark A Knepper; Chung-Lin Chou; Stasia A Anderson
Journal:  Kidney Int       Date:  2008-08-13       Impact factor: 10.612

2.  A genome search for primary vesicoureteral reflux shows further evidence for genetic heterogeneity.

Authors:  Maria Luisa Conte; Aida M Bertoli-Avella; Bianca M de Graaf; Francesca Punzo; Giuliana Lama; Angela La Manna; Carolina Grassia; Pier Francesco Rambaldi; Ben A Oostra; Silverio Perrotta
Journal:  Pediatr Nephrol       Date:  2008-01-16       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.